197 related articles for article (PubMed ID: 19833242)
21. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
[TBL] [Abstract][Full Text] [Related]
22. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
[TBL] [Abstract][Full Text] [Related]
23. Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells.
Hemmi H; Okuyama H; Yamane T; Nishikawa S; Nakano T; Yamazaki H; Kunisada T; Hayashi S
Biochem Biophys Res Commun; 2001 Jan; 280(2):526-34. PubMed ID: 11162550
[TBL] [Abstract][Full Text] [Related]
24. Influence of glucocorticoids on human osteoclast generation and activity.
Sivagurunathan S; Muir MM; Brennan TC; Seale JP; Mason RS
J Bone Miner Res; 2005 Mar; 20(3):390-8. PubMed ID: 15746983
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes.
Gallois A; Lachuer J; Yvert G; Wierinckx A; Brunet F; Rabourdin-Combe C; Delprat C; Jurdic P; Mazzorana M
J Bone Miner Res; 2010 Mar; 25(3):661-72. PubMed ID: 19775202
[TBL] [Abstract][Full Text] [Related]
26. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
27. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
Yoshida T; Flegler A; Kozlov A; Stern PH
J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
29. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
[TBL] [Abstract][Full Text] [Related]
30. c-myc is required for osteoclast differentiation.
Battaglino R; Kim D; Fu J; Vaage B; Fu XY; Stashenko P
J Bone Miner Res; 2002 May; 17(5):763-73. PubMed ID: 12009006
[TBL] [Abstract][Full Text] [Related]
31. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
[TBL] [Abstract][Full Text] [Related]
33. The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.
Hossain MA; Samuel CS; Binder C; Hewitson TD; Tregear GW; Wade JD; Bathgate RA
Amino Acids; 2010 Jul; 39(2):409-16. PubMed ID: 20043231
[TBL] [Abstract][Full Text] [Related]
34. Platelets increase while serum reduces the differentiation and activity of osteoclasts in vitro.
Agis H; Schröckmair S; Skorianz C; Fischer MB; Watzek G; Gruber R
J Orthop Res; 2013 Oct; 31(10):1561-9. PubMed ID: 23703957
[TBL] [Abstract][Full Text] [Related]
35. Relaxin has anti-apoptotic effects on human trophoblast-derived HTR-8/SV neo cells.
Lodhi RS; Nakabayashi K; Suzuki K; Yamada AY; Hazama R; Ebina Y; Yamada H
Gynecol Endocrinol; 2013 Dec; 29(12):1051-4. PubMed ID: 24070111
[TBL] [Abstract][Full Text] [Related]
36. Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systems.
Laitala-Leinonen T
J Negat Results Biomed; 2005 Aug; 4():5. PubMed ID: 16124882
[TBL] [Abstract][Full Text] [Related]
37. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis.
Yang M; Mailhot G; Birnbaum MJ; MacKay CA; Mason-Savas A; Odgren PR
J Biol Chem; 2006 Aug; 281(33):23598-605. PubMed ID: 16787916
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts.
Grano M; Mori G; Minielli V; Cantatore FP; Colucci S; Zallone AZ
Biochem Biophys Res Commun; 2000 Apr; 270(3):1097-100. PubMed ID: 10772956
[TBL] [Abstract][Full Text] [Related]
39. Bone matrix regulates osteoclast differentiation and annexin A8 gene expression.
Crotti TN; O'Sullivan RP; Shen Z; Flannery MR; Fajardo RJ; Ross FP; Goldring SR; McHugh KP
J Cell Physiol; 2011 Dec; 226(12):3413-21. PubMed ID: 21344395
[TBL] [Abstract][Full Text] [Related]
40. Hydroxyapatite surface roughness: complex modulation of the osteoclastogenesis of human precursor cells.
Costa-Rodrigues J; Fernandes A; Lopes MA; Fernandes MH
Acta Biomater; 2012 Mar; 8(3):1137-45. PubMed ID: 22178652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
